Anand Sampath is EVP, Ops & Clinical Research of MASIMO CORP. Currently has a direct ownership of 29,589 shares of MASI, which is worth approximately $4.27 Million. The most recent transaction as insider was on Feb 22, 2021, when has been sold 14,593 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.6K
0% 3M change
0% 12M change
Total Value Held $4.27 Million

Anand Sampath Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 22 2021
BUY
Grant, award, or other acquisition
-
14,593 Added 33.03%
29,589 Common Stock
Jan 02 2021
SELL
Payment of exercise price or tax liability
$210,947 $268.38 p/Share
786 Reduced 4.98%
14,996 Common Stock
Jan 02 2021
BUY
Exercise of conversion of derivative security
-
2,000 Added 11.25%
15,782 Common Stock
Dec 15 2020
SELL
Open market or private sale
$7,967,700 $265.59 p/Share
30,000 Reduced 68.52%
13,782 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$791,700 $26.39 p/Share
30,000 Added 51.04%
28,782 Common Stock
AS

Anand Sampath

EVP, Ops & Clinical Research
Irvine, CA

Track Institutional and Insider Activities on MASI

Follow MASIMO CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MASI shares.

Notify only if

Insider Trading

Get notified when an Masimo Corp insider buys or sells MASI shares.

Notify only if

News

Receive news related to MASIMO CORP

Track Activities on MASI